- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01161056
Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways (GAP)
Study Overview
Status
Conditions
Detailed Description
The primary purpose of this research is to develop a better understanding of how the immune system works. By studying immune function in many people, we will be able to determine the range of normal variation.
The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).
Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Manhasset, New York, United States, 11030
- The Feinstein Institute for Medical Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Over age 18
- Generally healthy
Exclusion Criteria:
- History of autoimmune disease
- History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV
- Currently undergoing treatment for cancer
- Current treatment with immuno-suppressant drugs
- Pregnancy
Study Plan
How is the study designed?
Cohorts and Interventions
Group / Cohort |
---|
Healthy Control Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of healthy participants enrolled
Time Frame: 5 years
|
This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control
|
5 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Peter Gregersen, MD, The Feinstein Institute for Medical Research
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-081A
- 1RC2AR059092-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Immune System Diseases
-
University of HelsinkiTampere UniversityCompletedImmune System DisordersFinland
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteers)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
SanofiTerminatedImmune System DisorderUnited States, Spain
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedGraft vs Host Disease | Immune System DisordersUnited States
-
Shanghai Henlius BiotechCompleted
-
University Hospital, LimogesCompleted
-
University Hospital, LilleLaboratoire français de Fractionnement et de BiotechnologiesCompleted